(Reuters) – Data from a late-stage study to test if AstraZeneca’s diabetes drug Farxiga could treat patients hospitalised with COVID-19 […]
Ocular Abnormalities Not Likely in Newborns of SARS-CoV-2-infected Mothers
(Reuters Health) – Unlike pathogens such as Cytomegalovirus and Zika, SARS-CoV-2 is not likely to cause ocular problems in newborns […]
Transplant Saves Selected Patients With Irreversible COVID-19 Lung Disease
(Reuters Health) – Double lung transplants are the only known way to save the lives of people with acute respiratory […]
CDC Updates Guidance to Cruise Ship Industry, Urges Vaccinations
WASHINGTON (Reuters) – The U.S. Centers for Disease Control (CDC) and Prevention on Friday issued new guidance to the cruise […]
EMA Advises Limited Use of Celltrion COVID-19 Antibody Drug, Says Benefits Still Unclear
(Reuters) – Europe’s drug regulator said on Friday South Korean drugmaker Celltrion’s COVID-19 treatment can be considered for patients at […]
First Two Brazilian COVID-19 Vaccines Ready for Human Trials
SAO PAULO (Reuters) – Brazil on Friday unveiled its first two domestically developed COVID-vaccine candidates for human trials, which although […]
Moderna Testing New COVID-19 Vaccine as Next-Generation Shot
(Reuters) – Moderna Inc said on Monday it had dosed the first patients in an early stage study of a […]
Hong Kong’s Tough COVID-19 Rules See Babies Isolated, Families Cramped in Tiny Spaces
HONG KONG (Reuters) – Families in Asia’s financial hub of Hong Kong are suffering isolation and trauma after strict coronavirus […]
EU Regulator Advises on Use of Lilly’s COVID-19 Antibody Cocktail
(Reuters) – Europe’s medicines regulator said on Friday Eli Lilly and Co’s antibody drug combination can be used to treat […]
Oxford Study Indicates AstraZeneca Effective Against Brazil Variant, Source Says
RIO DE JANEIRO (Reuters) – Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 […]